Announcement of Approval of OTP Accrediting Organizations

Center for Substance Abuse Treatment

December 4, 2001

Dear Opioid Treatment Program Sponsor:

This letter is to apprize you of significant developments affecting opioid treatment programs. On November 30, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the approval of four accreditation bodies (enclosed) under the new opioid treatment program regulations (42 CFR Part 8). The four accreditation bodies are:

Commission on Accreditation of Rehabilitation Facilities (CARF)

Joint Commission on Accreditation of Healthcare Organizations (JCAHO)

Council on Accreditation for Children and Family Services (COA)

Washington State Department of Social and Health Services, Division of Alcohol and Substance Abuse

We have enclosed additional contact information (see Fact Sheet) about these approved accreditation bodies.

You may recall, as a condition for “transitional certification” under SAMHSAs new regulation (42 CFR 8.11(d)), each OTP agreed to apply to an approved accreditation body within 90 days from the date SAMHSA approves accreditation bodies under the rule. Therefore, OTPs with transitional certification must apply to one of the above accreditation bodies by March 4, 2002. OTPs that have received “provisional certification” must achieve accreditation within one year of their provisional certification date (see 42 CFR 8.11(e)).

CSAT has received questions (enclosed) from OTPs that are presently accredited by one of the above approved accreditation bodies. These OTPs have asked about the need to have an accreditation survey conducted at this time. As noted in the preamble to the final rule (66 FR 4086, January 17, 2001), SAMHSA will consider the issue on a case-by-case basis. OTPs that believe they have current accreditation status that involve substantial compliance with the Federal opioid treatment standards under 42 CFR 8.12, should submit supporting documentation to that effect to SAMHSA at the following address: Center for Substance Abuse Treatment (OPAT), 1 Choke Cherry Road, Room 2-1075, Rockville, MD 20857

The preamble to the final rule also discussed SAMHSAs intention to reduce the economic burden associated with accreditation costs. Accordingly, on October 23, SAMHSA issued a Guidance for Applicants (GFA) to permit approved accreditation organizations to apply for and obtain grants to reduce accreditation inspection and training costs to OTPs.

Thank you for your cooperation in this important public health initiative.

Sincerely,

H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM

Director

Center for Substance Abuse Treatment

Enclosures

Similar Posts

  • Federal Agencies

    Admin 10/16/2022

    United States Regulations Code of Federal Regulations 42 Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Federal Register 17 January 2001. (PDF Format) Publication of Final Rule with comments. 42 Code of Federal Regulations Part 2 . Confidentiality of Alcohol and Drug Abuse Patient Records. New Take Home Regulations. Page 4098…

  • TEXNAMA

    Admin 08/25/2021

    Texas Alliance of Methadone Advocates We are dedicated to educating all methadone patients, counselors, familes, employers about the benefits of methadone. We are volunteers made up of patients, ex-patients, family members, employers, counselors, providers, doctors and you. We want to end the stigma associated with being on Methadone Maintence Treatment (MMT) by educating both patients…

  • Quick Links

    Admin 11/28/2022

    Treatment Facility Locator Buprenorphine Physician Locator Center for Substance Abuse Treatment US government search engine to locate all forms of drug treatment. Substance Abuse Mental Health Services Administration (SAMHSA) US government search engine to locate physicians prescribing Buprenorphine. Code of Federal Regulations Federal Register, January 17, 2001   CRF 42 Part 8 in text and…

  • Advisory Board Member Dr. Marc Shinderman Receives Paolo Picchio Award Recognizing Pioneers in the Field of Addiction Treatmen

    Admin 10/31/2021

    February 9, 2004 NAMA is pleased to announce that Dr. Marc Shinderman has been recognized in Europe for his pioneering work in addiction treatment medicine. The award was presented this past December during the European Methadone Conference (Pietrosanta, Italy). One of NAMA’s international affiliates, Roberto Nardini of Sociali Gruppo SIMS helped with the presentation. The…

  • Remember Us!

    Admin 06/03/2021

    The Writer Asks to Have Their Name Withheld for Fear of Retaliation Imagine — a young woman is in the Ladies Room stall, the Door is being held open by a worker whose job it is to observe the woman (any female patient) give a urine sample. This sample is tested for any drugs that…